Clinical Trials on Antibody Titer
Total 355 results
-
Sun Yat-sen UniversitySecond Affiliated Hospital of Guangzhou Medical UniversityCompletedLiver Diseases | Hepatocellular Carcinoma | Anti-PD1 AntibodyChina
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingChemotherapy Effect | Lung Cancer Stage IV | PD-1 Antibody | Lung Cancer Squamous CellChina
-
Johns Hopkins UniversityCompletedSystemic Lupus Erythematosus | Antiphospholipid Antibody SyndromeUnited States
-
Chinese SLE Treatment And Research GroupRecruitingANCA-associated Vasculitis | Maintenance TherapyChina
-
National University of MalaysiaMalaysia Automotive Robotics and Innovation of Technology InstituteCompletedAntibody | Vaccine | Maternal | CordMalaysia
-
Assistance Publique - Hôpitaux de ParisRoche Pharma AGCompletedComparison Between a Long Term and a Conventional Maintenance Treatment With Rituximab (MAINRITSAN3)ANCA-associated VasculitidesFrance
-
Hospital for Special Surgery, New YorkMontefiore Medical CenterCompletedSystemic Lupus Erythematosus | Antiphospholipid Syndrome | Thrombophilia Due to Antiphospholipid AntibodyUnited States
-
Columbia UniversityMerck Sharp & Dohme LLCCompletedImmunity; Defect Due to Antibody or Cell Mediated Immune DefectUnited States
-
Zhejiang Cancer HospitalNot yet recruitingGastric Cancer, HIPEC, Anti-PD-1 Antibody Camrelizumab (SHR-1210), Chemotherapy and SurgeryChina
-
Heinrich-Heine University, DuesseldorfDr. WetzchewaldUnknown
-
Shanghai First Maternity and Infant HospitalRecruitingCovid-19 | IgG Antibody | Semen IndexChina
-
Second Affiliated Hospital, School of Medicine,...RecruitingANCA Associated VasculitisChina
-
University of North Carolina, Chapel HillNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)SuspendedANCA Associated VasculitisUnited States
-
Lei LiCompletedChemotherapy | Recurrent Cervical Carcinoma | Immunotherapy | Anti-PD-1 Antibody | Persistent Advanced Cervical CarcinomaChina
-
Chinese SLE Treatment And Research GroupPeking Union Medical College HospitalRecruitingANCA Associated VasculitisChina
-
Centre Scientifique de MonacoDepartment of Health Affairs, MonacoRecruitingCOVID-19 | SARS-CoV-2 | Antibody | VaccinesMonaco
-
ChemoCentryxCompletedA Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis (ADVOCATE)ANCA-Associated VasculitisUnited States, Australia, Belgium, Canada, France, Italy, Japan, Netherlands, Spain, United Kingdom, Austria, Czechia, Denmark, Germany, Hungary, Ireland, New Zealand, Norway, Sweden, Switzerland
-
Wake Forest University Health SciencesWithdrawnCovid19 | Pregnancy Related | Antibody Response
-
Beijing Tongren HospitalNot yet recruitingBiomarker | Monoclonal Antibody | Chronic Rhino-sinusitis | IL-4RChina
-
GlaxoSmithKlineActive, not recruiting
-
University of PennsylvaniaNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsCompletedWegener's GranulomatosisUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedMycophenolate Mofetil to Treat Wegener's Granulomatosis and Related Vascular Inflammatory ConditionsVasculitis | Wegener's GranulomatosisUnited States
-
National Institute of Allergy and Infectious Diseases...Completed
-
Assistance Publique - Hôpitaux de ParisCompleted
-
David Grant U.S. Air Force Medical CenterWithdrawnSpike Protein IgG Antibody | COVID-19 Booster
-
Nippon Kayaku Co., Ltd.CompletedWegener's GranulomatosisUnited Kingdom, Germany, Sweden, Czech Republic, Denmark, Netherlands
-
National Institute of Allergy and Infectious Diseases...CompletedVasculitis | Wegener's GranulomatosisUnited States
-
National Institute of Allergy and Infectious Diseases...Completed
-
Assistance Publique - Hôpitaux de ParisFrench Vasculitis Study GroupActive, not recruitingMicroscopic Polyangiitis (MPA)France
-
Imperial College LondonBristol-Myers SquibbTerminated
-
Nordic Pharma SASTerminatedWegeners GranulomatosisCzech Republic
-
Hospices Civils de LyonUnknownChurg-Strauss SyndromeSwitzerland
-
West China HospitalRecruitingBRAF V600E-mutated /MSS Metastatic Colorectal Cancer | Vemurafenib (BRAFi) Plus Cetuximab (EGFRi) Combined With PD-1 Monoclonal AntibodyChina
-
Kedrion S.p.A.CompletedPrimary Immunodeficiency | Hypogammaglobulinemia | Agammaglobulinemia | Antibody DeficiencyUnited States, Canada
-
Mounzer AghaTerminated
-
National Institute of CancerologíaNational Heart Institute, Mexico; Pisa S.A de C.VCompletedPalliative Treatment | Cervical Cancer Recurrent or Persistent | Monoclonal Antibody in Cervical Cancer TreatmentMexico
-
Lei LiRecruitingChemotherapy | Recurrent Cervical Carcinoma | Immune Checkpoint Inhibitors | Anti-PD-1 Antibody | Persistent Advanced Cervical Carcinoma | Albumin-bound PaclitaxelChina
-
Shanghai Zhongshan HospitalRecruitingGranulomatosis With PolyangiitisChina
-
Cambridge University Hospitals NHS Foundation TrustRoche Pharma AGCompletedSystemic Lupus Erythematosus | ANCA Associated VasculitisUnited Kingdom
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...CompletedVasculitis | Wegener's GranulomatosisUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedVasculitis | Wegener's GranulomatosisUnited States
-
Mount Sinai Hospital, CanadaPfizer; Canadian Institutes of Health Research (CIHR)TerminatedRecurrent Pregnancy Loss | Antiphospholipid Antibody SyndromeCanada
-
Leiden University Medical CenterRecruitingANCA Associated VasculitisNetherlands
-
Jiangsu HengRui Medicine Co., Ltd.Shanghai Chest HospitalUnknownChemotherapy Effect | KRAS Gene Mutation | NSCLC Stage IV | PD-1 Antibody
-
Human Genome Sciences Inc., a GSK CompanyGlaxoSmithKlineCompletedVasculitisUnited States, Australia, France, Spain, Italy, Peru, Belgium, Canada, Germany, Romania, Mexico, United Kingdom, Hungary, Ireland, Poland, Switzerland, Czechia, Russian Federation, Norway, Sweden
-
University Hospital Schleswig-HolsteinGlaxoSmithKlineCompletedChurg Strauss SyndromeGermany
-
National Institute of Arthritis and Musculoskeletal...FDA Office of Orphan Products DevelopmentCompleted
-
Charles M KnudsonRecruitingAntibody-mediated Rejection | CIDP | NMO Spectrum Disorder | TTPUnited States
-
Sun Yat-sen UniversityCompletedBrain Metastases | NSCLC Stage IV | PD-1 AntibodyChina